Research has shown that eIF4E mediates enhanced translation of proto-oncogenes (Yang et al., 2023c), promotes proliferation and invasion of renal cancer (Li et al., 2017c), and is closely associated with sunitinib resistance (Chen et al., 2020b). Here, EIF4E is linked to renal carcinoma.